Cyclerion Therapeutics Inc CYCN:NASDAQ

RT Quote | USD
Last | 05/10/24 EDT
3.15quote price arrow up+0.15 (+5.00%)
Volume
369
52 week range
1.75 - 6.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.00
  • 52 Week High6.75
  • 52 Week High Date05/19/23
  • 52 Week Low1.75
  • 52 Week Low Date11/28/23

Key Stats

  • Market Cap8.537M
  • Shares Out2.71M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-5.97

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.00
  • 52 Week High6.75
  • 52 Week High Date05/19/23
  • 52 Week Low1.75
  • 52 Week Low Date11/28/23
  • Market Cap8.537M
  • Shares Out2.71M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-5.97

RATIOS/PROFITABILITY

  • EPS (TTM)-5.57
  • P/E (TTM)-0.57
  • Fwd P/E (NTM)-2.67
  • EBITDA (TTM)-7.99M
  • ROE (TTM)-158.12%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,979.44%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cyclerion Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing treatments for serious diseases. The Company’s portfolio includes novel soluble guanylate cyclase (sGC) stimulators, namely praliciguat and olinciguat, as well as multiple research stage molecules. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. Olinciguat is a vascular sGC stimulator that the...
Marsha Fanucci
Independent Chairman of the Board
Regina Graul Ph.D.
President
Cheryl Gault
Chief Operating Officer
Anjeza Gjino
Chief Financial Officer, Corporate Secretary
Address
301 Binney Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
NTBL
Notable Labs Ltd
1.25-0.23-15.54%
XBIO
Xenetic Biosciences Inc
3.90-0.15-3.62%
LGVN
Longeveron Inc
1.46-0.08-5.52%
INBS
Intelligent Bio Solutions Inc
2.34-0.13-5.26%
SCPX
Scorpius Holdings Inc
0.1766+0.0008+0.4352%